Ms. Chandra Ganjoo, Group Chief Executive Officer, Trivitron Healthcare, said, “Our dedicate R&D team has conducted an in-silico analysis, ensuring that Trivitron’s cutting-edge COVID-19 testing kits, including COVIDSure, COVIDSure PRO, and COVIDSure Direct RT-PCR Kits, possess the capability to effectively detect the heavily mutated JN.1 strain of the SARS-CoV-2 virus.

Visit Site